Merck Sharp & Dohme Inc is categorized under Commercial Medical Research in Boulder, CO .
Merck Sharp & Dohme Inc was established in 0, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Dave Mitchell, President at the company’s single location by writing to 2590 Central Avenue, Boulder, Colorado CO 80301 or by phoning (303) 339-5600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Merck Sharp & Dohme Inc |
| Contact Person: | Dave Mitchell, President |
| Address: | 2590 Central Avenue, Boulder, Colorado 80301 |
| Phone Number: | (303) 339-5600 |
| Website Address: | merck.com |
| Annual Revenue (USD): | $50.000.000 to $99.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 3254120 |
| Share This Business: |
Merck Sharp & Dohme Inc was started in 0 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.
Feel free to contact Dave Mitchell, President for inquiries that concern Merck Sharp & Dohme Inc by calling the company number (303) 339-5600, as your correspondence is most welcome. Additionally, the physical location of the single location of Merck Sharp & Dohme Inc can be found at the coordinates 40.02507,-105.21843 as well as the street address 2590 Central Avenue in Boulder, Colorado 80301.
For its online presence, you may visit Merck Sharp & Dohme Inc’s website at merck.com and engage with its social media outlets through on Twitter and on Facebook.